266 results
8-K
BDTX
Black Diamond Therapeutics Inc
9 May 24
Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:10am
)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 9, 2024
BLACK DIAMOND
THERAPEUTICS, INC.
(Exact name of registrant … provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On May 9, 2024, Black Diamond
8-K
EX-99.1
pzm ekddiw91n
9 May 24
Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:10am
DEFA14A
g3n7lctsy9rt txcyod
24 Apr 24
Additional proxy soliciting materials
4:02pm
PRE 14A
5aypx3lc h310
12 Apr 24
Preliminary proxy
4:48pm
8-K
EX-99.1
56uwy
11 Apr 24
Black Diamond Therapeutics Announces Changes to Board of Directors
8:03am
8-K
goy9yk3r
11 Apr 24
Black Diamond Therapeutics Announces Changes to Board of Directors
8:03am
S-8
EX-5.1
h08fr354m le6ahev
12 Mar 24
Registration of securities for employees
8:01am
S-8
txy jp1p4o7et1k
12 Mar 24
Registration of securities for employees
8:01am
S-8
EX-23.1
76svlw
12 Mar 24
Registration of securities for employees
8:01am
S-8
7bgbuz kfirq
12 Mar 24
Registration of securities for employees
8:01am